Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sherin Juliet Rouhani, M.D.,Ph.D.

Concepts (132)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Sherin Rouhani's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Sherin Rouhani has written about over time.
Immune Tolerance, 4 publications between 2010 and 2015, average publication date February 2013. Endothelial Cells, 5 publications between 2010 and 2019, average publication date April 2014. Antigen Presentation, 3 publications between 2010 and 2019, average publication date December 2014. Antigens, CD, 1 publications between 2015 and 2015, average publication date April 2015. CD4-Positive T-Lymphocytes, 1 publications between 2015 and 2015, average publication date April 2015. Dendritic Cells, 1 publications between 2015 and 2015, average publication date April 2015. Lymph Nodes, 6 publications between 2010 and 2022, average publication date June 2015. Lymphatic Vessels, 3 publications between 2012 and 2019, average publication date October 2015. Immunotherapy, 2 publications between 2021 and 2022, average publication date April 2022. Adrenal Insufficiency, 1 publications between 2022 and 2022, average publication date May 2022. Vaccines, Synthetic, 1 publications between 2022 and 2022, average publication date May 2022. Carcinoma, Non-Small-Cell Lung, 3 publications between 2021 and 2023, average publication date September 2022. Dermatitis, 1 publications between 2022 and 2022, average publication date October 2022.

To see the data from this visualization as text, click here.
Rouhani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (132)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.